Midi Health’s Post

Many people don’t realize that women weren’t required in U.S. clinical research until 1993. That’s an entire medical history without us, where the male body was used as the default human body, representing us all. The thalidomide birth defects of the 60s made it feel safer to exclude women entirely rather than risk research with people who could become pregnant. Plus, our pesky monthly fluctuations in hormones were inconveniently tricky to control for in research. But women are 50-75% more likely to have adverse drug reactions. Our heart attack symptoms are different. We’re at higher risk of overdose from anaestethia. Not to mention topics that were barely researched at all until recently, like menopause, the clitoris and pleasure, and pain dismissal by doctors. The research gaps are event wider for trans and non-binary people, people of color, and more. Couldn’t be happier to see companies like Evvy and Midi Health leading the way on spreading the word and closing the data gap. And a special thank you to Caroline Cristi Perez and her book Invisible Women, which crystallizes it all so beautifully. #invisiblewomen #healthequity #researchequity #clinicaltrials #womenshealth #equalresearchday

Ok, ladies - I think we have had enough and are past ready to take control of our health, especially as we age. The article succinctly explains just how inadequately our current healthcare systems support women throughout their lives. For example: 👉 Health Research Bias: The article highlights the disparity in medical research, with men being the focus more than women, especially older women. Here's an example cited in the article (and there are numerous others if you look around): "A supplementary appendix to a Leqembi study published in the New England Journal of Medicine revealed that sex differences were substantial — a 12 percent slowdown for women, compared with a 43 percent slowdown for men — raising questions about the drug’s effectiveness for women." (Notice it was *supplementary* info.) 👉 Older Women’s Health: Women are more prone to multiple medical conditions, disabilities, and mental health issues compared to older men. Did you know that? I'm hoping innovators like Dr. Suzanne Steinbaum, Susan Sly, Geetha Manjunath, Mariam Khayretdinova, Kirthika Parmeswaran and many, many others will help us treat women as women and not just as smaller men. Sara Rico Ksheerja Batra Colleen Healy Patricia Obermaier Rose Wang #womenshealth #femtech #cardiaccare #mentalhealth #femalefounders https://lnkd.in/enma9QTW

Absolutely agree with you, Sally Ann Frank, that women are not small men and deserve better care! It’s shocking to remember that women were not included in clinical trials until 1993. That says it all! This gap still needs to be closed, which is why NNABI was created – to support women in perimenopause so they can thrive instead of suffer needlessly. When it comes to women's health in midlife, we hear about fertility and menopause, but not enough about perimenopause, even though all women experience it, starting as early as 35 and lasting for over 10 years until menopause. We need businesses, investments, innovations, and conversations to catch up. It's not about competition; it's about the collision of efforts driving change. How are you contributing to the solution?

On International Women’s Day, it’s important to acknowledge the achievements made in understanding and addressing women’s health, especially in conditions like multiple sclerosis (MS). Recently, researchers embarked on a collaborative effort to identify key priorities for investigating women's health issues in MS. This initiative provides a roadmap for future studies to address critical gaps in knowledge and improve care outcomes for women living with MS. Find out more 👉 https://bit.ly/3V3PDhS #IWD #IWD2024 #InternationalWomensDay💜

For most of history, women’s health has been neglected across science, medicine, and technology. Earlier this year, the World Economic Forum, the McKinsey Health Institute and a cross-sector public-private coalition championed by Ferring, released a report revealing the $1 trillion potential of closing the gender health gap. This research highlights the opportunity to improve the lives of 3.9 billion women worldwide and boost the global economy by investing in women's health. In the latest issue of Biopharma Dealmakers, Kelle Moley, Global VP of Clinical and Translational R&D, Reproductive Medicine and Maternal Health at Ferring, shares her thoughts on the progress made so far, and the change we still need to see. Read more: https://lnkd.in/edShebXp #CloseTheWomensHealthGap #MaternalHealth #WomensHealth

Women's Health Innovation suffers from lack of funding - from early stage research to market ready product! Sign up for the BioInnovation Institute's webinar on June 6 to learn how the BII supports Women's Health through the Venture Lab Program, and how you can accelerate your innovation 🚀 🌟 ♀ Trine Bartholdy Johanna Roostalu Cathrine Nygaard Christensen Angela Ibler

Women continue to fight a long battle for equal rights and fair treatment in the workplace, boardrooms, and the medical arena. Currently, we are seeing gender discrepancy in one of the most frightening and devastating conditions of modern times, Alzheimer’s Disease (AD). So much more work needs to be done (and is finally being done) to unravel the intricacies of the female connection to AD. A very interesting and relevant article by Dr Frank Sabatino, DC, PhD, posted on the T. Colin Campbell Center for Nutrition Studies website. #veganbusiness #plantbased #womenshealth

COVID-19 and Stroke: How Gender Affects Women's Health #COVID19andstroke #COVID19andwomenshealth #genderdisparitiesinstroke #genderspecificriskfactorsforstroke #strokeincidenceandmanagement

Significant gender and race disparities have been observed in the care of patients with myasthenia gravis (MG). Gender Disparities: - Women are more likely to undergo a thymectomy. - Women are less likely to receive chest computed tomography. - Women are less likely to be prescribed pyridostigmine and steroid-sparing agents. Race Disparities: - Black patients with MG are less likely to receive pyridostigmine and chest CTs compared to other racial groups. Read more: https://brnw.ch/21wLPt9 #RareDisease

As we acknowledge National Women's Health Awareness Month, let's turn our attention to a condition that affects millions of women worldwide: Endometriosis. This often misunderstood and underdiagnosed condition can have a profound impact on women's lives, underscoring the urgent need for increased awareness and innovative diagnostic approaches. #Endometriosis is a chronic condition where tissue similar to the lining of the uterus grows outside the uterus, causing pain, infertility, and other debilitating symptoms. Despite its prevalence, diagnosing endometriosis can be challenging, leading to delays in treatment and unnecessary suffering for patients.   This Women's Health Awareness Month, let's emphasize the importance of #MolecularImaging in revolutionizing the diagnosis and management of endometriosis. Molecular imaging techniques, such as positron emission tomography (#PET) and magnetic resonance imaging (#MRI), offer a non-invasive way to visualize and characterize endometrial lesions with unprecedented precision. We highlight recent publications by Prof. Anna Moore's group at Michigan State University focused on non-invasive detection of endometriosis. This recent publication (https://lnkd.in/drA3uamx) does so by using a gadolinium-based collagen type I targeting probe developed by their lab. Another study led by her group (https://lnkd.in/d52bWC22) evaluated cRGD-peptide-conjugated nanoparticles (RGD-Cy5.5-MN) for endometriosis lesion detection. Together, let's empower women to take control of their reproductive health and break the silence surrounding endometriosis. 💖 #WomensHealth #EndometriosisAwareness #MolecularImaging #Empowerment